Chinese Version of Fibromyalgia Criteria and Severity Scales Study
The Chinese Version of the Modified American College of Rheumatology (ACR) Diagnostic Criteria for Fibromyalgia and the Fibromyalgia Impact Questionnaire: Reliability and Validity
1 other identifier
observational
327
1 country
1
Brief Summary
Up to now, there is no Chinese version of fibromyalgia diagnosis criteria and severity assessment scales. The aim of this study is to translate, adapt, and validate the Chinese version of the 2011 modification of the 2010 ACR preliminary criteria for the diagnosis of fibromyalgia (2011ModCr) and 2016 ACR revisions to the 2010/2011 fibromyalgia diagnostic criteria, as well as the Fibromyalgia Impact Questionnaire (FIQ-C).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2017
CompletedFirst Posted
Study publicly available on registry
December 21, 2017
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedJanuary 25, 2022
January 1, 2022
3.2 years
December 18, 2017
January 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the Chinese Version of Fibromyalgia Impact Questionnaire (FIQ-C)
This questionnaire was designed to assess the current health status of patients with fibromyalgia. The FIQ has 11 individual questions and measures physical functioning, work status (missed days of work and job difficulty), depression, anxiety, morning tiredness, pain, stiffness, fatigue, and well-being over the past week ranging from 0-100 with higher score indicating more severity.
up to 1 week
Secondary Outcomes (4)
Widespread pain index (WPI)
up to 1 week
Symptom severity scale (SSS)
up to 1 week
the polysymptomatic distress (PSD) scale
up to 1 week
the Chinese Version of the Revised Fibromyalgia Impact Questionnaire (FIQR-C)
up to 1 week
Eligibility Criteria
The fibromyalgia patients who meet the ACR 1990 criteria for diagnosis without psychiatric disorders other than depression will be recruited. During the study period, other patients with diseases associated with chronic pain, such as rheumatoid arthritis (RA), osteoarthritis (OA), and gout, who have not been diagnosed previously with fibromyalgia will be recruited as control patients. An experienced rheumatologist familiar with fibromyalgia assessed these patients.
You may qualify if:
- Age 18 years or older.
- Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for Fibromyalgia.
You may not qualify if:
- Without any psychiatric disorders other than depression.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guang'anmen Hospital
Beijing, Beijing Municipality, 100053, China
Related Publications (2)
Jiao J, Cheng ZY, Xiao YY, Wang H, Zhang YF, Zhao YY, Jia Y. Validation of the 2011 and 2016 American college of rheumatology diagnostic criteria for fibromyalgia in a Chinese population. Ann Med. 2023;55(2):2249921. doi: 10.1080/07853890.2023.2249921.
PMID: 37634058DERIVEDLi YT, Jiang Q, Jia Y, Zhang YF, Xiao YY, Wang H, Zhao YY, Jiao J. A Chinese version of the revised Fibromyalgia Impact Questionnaire: A validation study. Int J Rheum Dis. 2023 Feb;26(2):242-249. doi: 10.1111/1756-185X.14472. Epub 2022 Oct 19.
PMID: 36261882DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy chief physician
Study Record Dates
First Submitted
December 18, 2017
First Posted
December 21, 2017
Study Start
October 1, 2018
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
January 25, 2022
Record last verified: 2022-01